Sameridine (NIH-10908) is a weak partial agonist of the µ-opioid (µ-opioid) receptor. Sameridine shows local anesthetic and analgesic properties when injected intrathecally. Sameridine has minimal respiratory depression at low doses, but can suppress ventilatory response at high doses. Sameridine can be used for the study of analgesic effect[1][2].
Molecular Weight:
330.51
CAS Number:
[143257-97-0]
Formula:
C21H34N2O
Target:
Opioid Receptor
Application Notes:
MCE Product type: Reference compound
* VAT and and shipping costs not included. Errors and price changes excepted
